How to protect the kidney in diabetic patients: with special reference to IDDM.
about
Glucose targets for preventing diabetic kidney disease and its progressionPentoxifylline for diabetic kidney diseaseAntihypertensive agents for preventing the progression of diabetic kidney diseaseHeparin and related substances for preventing diabetic kidney diseaseSodium ferulate for preventing the progression of diabetic kidney diseaseAntihypertensive agents for preventing the progression of diabetic kidney diseasePentoxifylline for diabetic kidney diseaseHeparin and related substances for preventing diabetic kidney diseaseAntihypertensive agents for preventing diabetic kidney diseaseAntihypertensive agents for preventing diabetic kidney diseaseDetection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up studyResequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.Drug treatment for hypertensive patients in special situations: diabetes and hypertension.Identification of non-diabetic glomerular disease in renal biopsies from diabetics--a dilemma.NGAL as an Early Predictive Marker of Diabetic Nephropathy in Children and Young Adults with Type 1 Diabetes Mellitus.Hypoglycaemia and associated hypokalaemia in diabetes: mechanisms, clinical implications and prevention.C-peptide and diabetic kidney disease.Haemodynamics in microvascular complications in type 1 diabetes.Correlation between periodontitis and chronic kidney disease in Korean adultsDoes renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?Diabetic nephropathy in children and adolescents.Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors.Update on blood pressure control and renal outcomes in diabetes mellitus.Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.The role of renin angiotensin system inhibition in kidney repair.Early renal histological changes in alloxan-induced diabetic rats.Evaluation of glomerular filtration rate using cystatin C in diabetic patients analysed by multiple factors including tubular function.Effects of Opuntia megacantha leaves extract on renal electrolyte and fluid handling in streptozotocin (STZ)-diabetic rats.Sudden death in young patients with Type 1 diabetes: a consequence of disease, treatment or both?Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy.Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.Proteome profiling in the aorta and kidney of type 1 diabetic rats.A comparison of the plasma disappearance of iohexol and 99mTc-DTPA for the measurement of glomerular filtration rate (GFR) in diabetes.Genetics of diabetic nephropathy and microalbuminuria.
P2860
Q24198925-5F737090-D4CF-4BC2-A63F-581396B63606Q24203643-4B1516F4-DA3A-4729-BD66-781622ADAC2FQ24234995-C514F4C1-9AF1-4390-8562-5B5AB10B3135Q24235372-B1120BEA-FF40-4C7D-84C3-C754539C56A0Q24236054-1DFAE38A-57FF-4DF1-89FB-D1A246126D1DQ24240735-403D723F-5A34-4130-B196-2637D468423FQ24243734-6B14B3BE-8794-4872-B809-F322EEDE8A05Q24245107-64A2A26B-0848-4685-97FE-E432F1D8E139Q24245557-EDE84977-7539-4984-B81D-2C8F18A9E61AQ24250062-4AA93C94-34F8-4B57-89F8-2F9501D907D9Q24654287-1CAD3261-B1A8-4AAC-8DE0-FE082ECC0A85Q30830157-76E13FC5-A3B6-409A-A71C-CF70BF3CC64AQ33697713-7EB62AE1-D72E-4624-8271-EA223E5AF67AQ33720219-4E2D52AA-9B6E-41E7-9465-AFEC53281D78Q33767888-CD847B61-E93B-4920-B16C-9AA480FD26C7Q34163348-9B8103F9-3C1A-4E40-9837-70D00ED2AE29Q34540591-9C163EDD-6C7A-43B0-BBE7-02E9491444DAQ34804249-F551B0EA-B8DE-4749-B31F-66B42D138106Q36465883-938D61D5-D49C-4580-B0A9-02FDE703354DQ36948768-06A36D71-5BCC-41F0-8607-51EE3054B03CQ36973440-53A1DB38-B81F-4802-878C-06692973BB2FQ38130262-5EA30597-DF26-4D04-AED9-36E9523B69E0Q38492248-7A0DAEB3-6B92-47E8-8D7A-E436FB2C2FE8Q38908409-F6EF8848-8085-426D-8B87-095850352AFCQ41206891-228DB871-1A47-497F-A64D-D25C78BAB3E9Q41961927-B131656D-5109-4784-8E55-DC758CEF8EA7Q43048731-25A888CA-9878-4651-A266-A24C6425C964Q43647649-B908FC29-4ED3-4F20-BF58-3723DD4F3E20Q44049894-F755A987-8EE6-4AF8-ADC2-1C6F7048B841Q45148071-803EE62D-684C-42B5-AFAE-F0C272193D9BQ46519015-4D691D4C-304D-4283-9385-CCA1AA541059Q46754754-AA4E6909-4574-45DE-AB9D-15A6CFC467B7Q47151238-5227DB1A-31FC-49E8-B12F-3717F6E9E511Q52083070-F91EDC51-25A2-4F1E-8FA2-5A6A7344C153Q54984063-D96ED85E-9B0E-4A24-96B6-5885FEDB6981
P2860
How to protect the kidney in diabetic patients: with special reference to IDDM.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
How to protect the kidney in diabetic patients: with special reference to IDDM.
@en
type
label
How to protect the kidney in diabetic patients: with special reference to IDDM.
@en
prefLabel
How to protect the kidney in diabetic patients: with special reference to IDDM.
@en
P356
P1433
P1476
How to protect the kidney in diabetic patients: with special reference to IDDM.
@en
P2093
Mogensen CE
P304
P356
10.2337/DIAB.46.2.S104
P407
P478
46 Suppl 2
P577
1997-09-01T00:00:00Z